Home » Posts tagged with » California
Element Biosciences raises $80m for genomic sequencing solutions

Element Biosciences raises $80m for genomic sequencing solutions

Californian biotechnology startup Element Biosciences, which focuses on developing genomic sequencing solutions for research and diagnostic markets, has raised $80.3 million in a Series B financing round. The financing round saw the entry of new investors Fidelity Management & Research and JS Capital alongside participation from existing investors Foresite Capital and Venrock. The US biotechnology startup […]

Lilly to acquire US dermatology drug company Dermira for $1.1bn

Lilly acquisition of Dermira : US pharma giant Eli Lilly and Company (Lilly) has agreed to acquire California-based dermatology drug company Dermira for about $1.1 billion in an all-cash deal as per the latest pharma acquisition news. Dermira, which is being acquired for $18.75 per share, has been engaged in developing dermatology products for the […]

Continue reading …
TERN-201 NASH clinical trial : Terns reports positive results for phase 1 study

TERN-201 NASH clinical trial : Terns Pharmaceuticals said that an ongoing phase 1 trial of its semicarbazide-sensitive amine oxidase (SSAO) inhibitor TERN-201 in non-alcoholic steatohepatitis (NASH) has yielded positive results. According to the US biopharma company, the early-stage NASH clinical study showed that a single oral dose of TERN-201 delivered a sustained, near-complete suppression of […]

Continue reading …
PACT Pharma raises $75m to develop neoTCR-T cell therapies for solid tumors

PACT Pharma, a California-based clinical stage company, which is focused on developing fully personalized neoTCR-T cell therapies for solid tumors, has raised $75 million in a Series C financing round. The funding round was led by Vida Ventures, a life science venture firm, with participation from the current investors of PACT Pharma. The clinical stage […]

Continue reading …
J&J takeover of Verb Surgical : J&J strikes deal with Verily for full ownership in robotic surgery company

J&J takeover of Verb Surgical : Johnson & Johnson (J&J) has agreed to take full ownership in US robotic surgery company Verb Surgical by acquiring the remaining stake it previously did not own from its joint venture partner Verily Life Sciences, an Alphabet company. The joint venture for the development of surgical robotic systems was […]

Continue reading …
Glaukos closes Avedro acquisition to expand corneal health franchise

Glaukos acquisition of Avedro : Glaukos Corporation, a California-based ophthalmic medical technology and pharmaceutical company, has completed its previously announced acquisition of Avedro. Based in Waltham, Massachusetts, Avedro is a hybrid ophthalmic pharmaceutical and medical technology company, which is focused on treating corneal disease and disorders and enhancing vision to decrease dependency on eyeglasses or […]

Continue reading …
AbbVie, Scripps Research to collaborate on developing new therapeutics

US biopharma company AbbVie has entered into a collaboration with California-based nonprofit medical research facility Scripps Research with a goal to develop new therapies for a variety of diseases, including in the therapeutic areas of oncology, immunology, fibrosis, and neurology. Peter Schultz – CEO of Scripps Research and Calibr, its drug discovery unit, said: “Based […]

Continue reading …
Astellas Pharma to acquire US gene therapy company Audentes Therapeutics

Astellas acquisition of Audentes: Japanese pharma company Astellas Pharma has agreed to acquire US gene therapy company Audentes Therapeutics in an all-cash deal worth about $3 billion, as per pharma acquisition news. Based in California, Audentes Therapeutics calls itself a clinical-stage company focused on developing a portfolio of Adeno-associated virus (AAV)-based genetic medicines for the […]

Continue reading …
Global Blood Therapeutics bags Oxbryta FDA approval for sickle cell disease

Oxbryta FDA approval : Global Blood Therapeutics (GBT), a California-based biopharma company, has bagged approval for Oxbryta (voxelotor) tablets from the US Food and Drug Administration (FDA) for sickle cell disease (SCD). The FDA approval of Oxbryta is for the treatment of adults and children, aged 12 years of age and older, who are suffering […]

Continue reading …
Mynosys Cellular Devices raises $25m from Decheng Capital

Mynosys Cellular Devices, which manufactures the Zepto cataract surgery device, has secured $25 million in a funding round led by investment firm Decheng Capital. The California-based ophthalmic technology company intends to use the funds to accelerate its growth in the US market and also to build a strong and sustainable R&D, manufacturing and commercial organization. […]

Continue reading …
Page 1 of 41234